Fig 1.
Flow diagram of molecular and serologic testing for ZIKV infection using qRT-PCR, IgM, IgG3, and PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.
Fig 2.
ZIKV-specific qRT-PCR results in relation to time since rash onset.
Fig 3.
Among women with qRT-PCR-confirmed ZIKV, (A) ZIKV-specific IgM results within 90 days of rash onset and (B) ZIKV-specific PRNT50 results within 1 year of rash onset.
Fig 4.
Robust evidence for ZIKV infection in pregnancy based on the results of qRT-PCR, IgM, IgG3, and PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.
Fig 5.
Moderate evidence for ZIKV infection in pregnancy based on the results of IgM, IgG3, and PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.
Fig 6.
Limited evidence for a ZIKV infection before, during, or after pregnancy based on the results of IgM and PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.
Fig 7.
Limited evidence for an unspecified flavivirus infection before or during pregnancy based on the results of PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.
Fig 8.
Evidence against a ZIKV infection in pregnancy based on the results of qRT-PCR, IgM, IgG3, and PRNT50 in a cohort of pregnant women with rash in Pernambuco, Brazil.